Search
for
Sort by
Research 151–180 of 771
- Prescribing testosterone and DHEA: The role of androgens in women
- Anti-aging Properties of Conditioned Media of Epidermal Progenitor Cells Derived from Mesenchymal Stem Cells
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Adverse health effects of androgen use
- Potassium channel openers: therapeutic potential in cardiology and medicine
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- p75 Neurotrophin Receptor Antagonist Retards Apoptosis-driven Hair Follicle Involution (Catagen)
- Alopecia Areata
- Group IID, IIE, IIF and III secreted phospholipase A2s
- Cicatricial alopecia
- Icariin promotes mouse hair follicle growth by increasing insulin-like growth factor 1 expression in dermal papillary cells
- Alopecia.
- INTERFERONS IN DERMATOLOGY
- Human umbilical cord blood mesenchymal stem cells engineered to overexpress growth factors accelerate outcomes in hair growth
- Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries
- Skin signs of systemic diseases
- Yellow and orange in cutaneous lesions: clinical and dermoscopic data
- Ashy Dermatosis
- Migration Inhibitory Factor in Conditioned Medium from Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells Stimulates Hair Growth
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- Protein-losing Enteropathy Exacerbated with the Appearance of Symptoms of Systemic Lupus Erythematosus.
- Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Systemic causes of hair loss
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Insulin resistance is increased in alopecia areata patients
- Melatonin-Loaded Nanocarriers: New Horizons for Therapeutic Applications
- Lessons Learned from the First Decade of Laser-Assisted Drug Delivery
- From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?